Featured Research

from universities, journals, and other organizations

Continuous oral contraceptive pills offer women earlier pain relief

Date:
August 15, 2012
Source:
Penn State
Summary:
Taking oral contraceptives continuously, rather than as traditionally prescribed for each cycle, provides earlier relief for moderate to severe menstrual cramps -- dysmenorrhea -- according to researchers at Penn State College of Medicine.

Taking oral contraceptives continuously, rather than as traditionally prescribed for each cycle, provides earlier relief for moderate to severe menstrual cramps -- dysmenorrhea -- according to researchers at Penn State College of Medicine.

Related Articles


Dysmenorrhea occurs during menstruation, resulting from abnormal uterine contractions, increased sensitivity to pain and added pressure in the pelvic area. It is often accompanied by nausea, vomiting, diarrhea, headache and fatigue.

"Between 50 and 90 percent of women suffer from this condition, and it can really limit work, school, or athletic performance," said Dr. Richard Legro, professor of obstetrics and gynecology. "Previous studies have estimated that dysmenorrhea accounts for 600 million lost work hours and $2 billion annually."

Participants in this study suffered from unexplained menstrual pain. Their pain was not attributable to previous surgeries, ovarian cysts, endometriosis, or other pelvic or bowel diseases. Results were published in Obstetrics and Gynecology.

"Oral contraceptives are often prescribed to treat this condition, since reducing menstruation is a relatively straightforward way to relieve this cramping," said Legro. "However, we wanted to determine whether there was a measurable difference between cyclic and continuous oral contraceptive treatment methods."

Cyclic treatment with oral contraceptives mimic a woman's natural cycle by preventing menstruation for 21 days, then stopping the pills for the next 7 so bleeding can occur. The continuous method consists of 28 days of active contraception, with no break for menstruation.

After six months of evaluation, both treatment groups experienced a significant reduction in menstrual pain. However, women taking the continuous contraceptive treatment reported significant pain relief earlier due to the uninterrupted nature of treatment.

While there is little or no difference in the composition of these two methods -- only the time they're taken -- there are different side effects with each. Patients should consult their doctor before making any changes to their regimen, as further research is needed to determine the risk-to-benefit ratio of extended use of continuous contraception for treatment of primary dysmenorrhea.

Other researchers on this project are Romana Dmitrovic of the BetaPlus Center for Reproductive Medicine in Zagreb, Croatia, who was the lead clinical investigator, and Allen R. Kunselman, senior instructor, Department of Public Health Sciences, Penn State College of Medicine.

The National Institute of Child Health and Human Development of the National Institutes of Health funded this study.


Story Source:

The above story is based on materials provided by Penn State. Note: Materials may be edited for content and length.


Journal Reference:

  1. Romana Dmitrovic, Allen R. Kunselman, Richard S. Legro. Continuous Glucose Monitoring During Pregnancy in Women With Polycystic Ovary Syndrome. Obstetrics & Gynecology, 2012; 119 (2, Part 1): 384 DOI: 10.1097/AOG.0b013e318244ac17

Cite This Page:

Penn State. "Continuous oral contraceptive pills offer women earlier pain relief." ScienceDaily. ScienceDaily, 15 August 2012. <www.sciencedaily.com/releases/2012/08/120815151618.htm>.
Penn State. (2012, August 15). Continuous oral contraceptive pills offer women earlier pain relief. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2012/08/120815151618.htm
Penn State. "Continuous oral contraceptive pills offer women earlier pain relief." ScienceDaily. www.sciencedaily.com/releases/2012/08/120815151618.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins